KR102483343B1 - Sparassis crispa extract with enhanced functional components - Google Patents
Sparassis crispa extract with enhanced functional components Download PDFInfo
- Publication number
- KR102483343B1 KR102483343B1 KR1020210155636A KR20210155636A KR102483343B1 KR 102483343 B1 KR102483343 B1 KR 102483343B1 KR 1020210155636 A KR1020210155636 A KR 1020210155636A KR 20210155636 A KR20210155636 A KR 20210155636A KR 102483343 B1 KR102483343 B1 KR 102483343B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- mushroom
- zinnia
- dried
- zinnia mushroom
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 84
- 241000272503 Sparassis radicata Species 0.000 title abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 46
- 238000004519 manufacturing process Methods 0.000 claims abstract description 23
- 238000001035 drying Methods 0.000 claims abstract description 19
- 238000005507 spraying Methods 0.000 claims abstract description 19
- 238000000605 extraction Methods 0.000 claims abstract description 12
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 127
- 241000801064 Zinnia Species 0.000 claims description 91
- 238000001914 filtration Methods 0.000 claims description 27
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims description 7
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims description 7
- 244000124209 Crocus sativus Species 0.000 claims description 4
- 235000015655 Crocus sativus Nutrition 0.000 claims description 4
- 239000001599 crocus sativus l. flower extract Substances 0.000 claims description 4
- 235000013974 saffron Nutrition 0.000 claims description 4
- 239000004248 saffron Substances 0.000 claims description 4
- 229940076591 saffron extract Drugs 0.000 claims description 4
- 238000000034 method Methods 0.000 abstract description 6
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 32
- 210000004027 cell Anatomy 0.000 description 13
- 239000003153 chemical reaction reagent Substances 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 10
- 229920002498 Beta-glucan Polymers 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 230000003833 cell viability Effects 0.000 description 7
- 210000002540 macrophage Anatomy 0.000 description 7
- 239000007974 sodium acetate buffer Substances 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 239000002158 endotoxin Substances 0.000 description 5
- 229920006008 lipopolysaccharide Polymers 0.000 description 5
- 229920001503 Glucan Polymers 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000021067 refined food Nutrition 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000004519 grease Substances 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000003260 vortexing Methods 0.000 description 3
- 229920000310 Alpha glucan Polymers 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 2
- 241001192908 Phlomis umbrosa Species 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000005965 immune activity Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010022769 Glucan 1,3-beta-Glucosidase Proteins 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229940027779 persimmon extract Drugs 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/50—Concentrating, enriching or enhancing in functional factors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 (1) 속단에 물을 첨가하고 추출한 후 여과하여 속단 추출액을 제조하는 단계; (2) 여뀌잎에 물을 첨가하고 추출한 후 여과하여 여뀌 추출액을 제조하는 단계; (3) 꽃송이버섯에 상기 (1)단계의 제조한 속단 추출액을 분무하는 단계; (4) 상기 (3)단계의 분무한 꽃송이버섯을 건조하는 단계; (5) 상기 (4)단계의 건조한 꽃송이버섯에 상기 (2)단계의 제조한 여뀌 추출액을 분무하는 단계; (6) 상기 (5)단계의 분무한 꽃송이버섯을 건조하는 단계; 및 (7) 상기 (6)단계의 건조한 꽃송이버섯에 물을 첨가한 후 추출하는 단계를 포함하여 제조하는 것을 특징으로 하는 꽃송이버섯 추출물의 제조방법 및 상기 방법으로 제조된 꽃송이버섯 추출물에 관한 것이다.The present invention comprises the steps of (1) preparing a quick-stage extract by adding water to the quick-stage, extracting, and then filtering; (2) adding water to the leaves, extracting them, and then filtering to prepare an extract; (3) spraying the quick-release extract prepared in step (1) on the zinnia mushroom; (4) drying the sprayed zinnia mushroom of step (3); (5) spraying the dried zinnia extract prepared in step (2) on the dried zinnia mushroom in step (4); (6) drying the sprayed zinnia mushroom of step (5); and (7) adding water to the dried cauliflower mushroom in step (6) and then extracting it.
질병의 치료 및 예방에 효과가 있는 천연물 중 가장 주목받고 있는 버섯은 종래 식용으로만 주로 이용되어 왔는데 우수한 약리효능이 계속해서 밝혀짐에 따라 건강 기능성 식품 신소재로서 버섯의 소비 역시 꾸준히 증가하고 있다. 현재 한국산 버섯의 경우 992종이 분류되어 있으며 그 중 식용 가능한 버섯이 100여 종, 독버섯은 50여 종이 존재한다. 또한 약용으로 사용하는 버섯은 35과 82속 162종으로 보고되고 있으나, 그 나머지 버섯은 아직 확인된 바가 없다. 생활수준의 향상으로 현대사회에서는 건강증진과 노화억제에 관심이 높아지면서 식품으로 섭취 가능한 항균, 항산화, 항암 효과를 지닌 천연물에 관한 활발한 연구를 진행하고 있다.Mushrooms, which have attracted the most attention among natural products effective in the treatment and prevention of diseases, have been mainly used only for food in the past. Currently, 992 species of Korean mushrooms are classified, and among them, there are about 100 edible mushrooms and 50 poisonous mushrooms. In addition, mushrooms used for medicinal purposes are reported as 162 species in 35 families and 82 genera, but the rest of the mushrooms have not yet been identified. With the improvement of living standards, interest in health promotion and anti-aging has increased in modern society, and active research is being conducted on natural substances that can be consumed as food and have antibacterial, antioxidant, and anticancer effects.
꽃송이버섯(Sparassis crispa)은 한국·일본·유럽·북아메리카·오스트레일리아 등지에 자생하며, 주로 침엽수 자른 그루터기나 고목 언저리에서 자생한다. 자실체의 지름은 10~30 cm의 크기이며, 높이는 10~25 cm로 육질이고, 밑부분은 굵은 줄기로 자루로 되어 있으며, 여러 차례 가지를 쳐서 꼭대기는 편평하게 되고 그 가장가리가 물결 모양이다. 상기 꽃송이 버섯의 자실층은 꽃잎 뒷면에 발달하였으며, 자루는 길이 2~5 cm, 나비 2~4 cm로 짧고 뭉툭하며 단단하다. 또한, 조직은 흰색이며, 포자는 길이 5~7 ㎛, 나비 3~5 ㎛로 달걀 모양 또는 타원형이고 표면은 평편하며 포자는 흰색이다. 상기 꽃송이버섯은 베타 글루칸의 다량보유(건조 자실체 100그램당 43.6그램 함유)함이 알려지면서 인공재배법에 대한 연구가 급속도로 진행되고 있다.Cinnamon mushroom ( Sparassis crispa ) is native to Korea, Japan, Europe, North America, Australia, etc., and mainly grows wild on the stump of coniferous trees or the edge of dead trees. The diameter of the fruiting body is 10-30 cm in size, the height is 10-25 cm, it is fleshy, and the lower part is a stalk with a thick stem. The fruiting layer of the zinnia mushroom developed on the back of the petals, and the stalk is short, blunt, and hard with a length of 2 to 5 cm and a width of 2 to 4 cm. In addition, the tissue is white, and the spores are egg-shaped or oval with a length of 5 to 7 μm and a width of 3 to 5 μm, and the surface is flat and the spores are white. As it is known that the zinnia mushroom has a large amount of beta glucan (containing 43.6 grams per 100 grams of dry fruiting body), research on artificial cultivation methods is rapidly progressing.
한국등록특허 제1513712호에는 수용성 식이섬유 함량이 증진된 꽃송이버섯 발효 추출물의 제조방법이 개시되어 있고, 한국등록특허 제1068699호에는 꽃송이버섯 추출물을 포함하는 항산화 활성을 갖는 조성물이 개시되어 있으나, 본 발명의 기능성 성분이 증진된 꽃송이버섯 추출물과는 상이하다.Korean Patent No. 1513712 discloses a method for producing a fermented zinnia mushroom extract with increased water-soluble dietary fiber content, and Korean Patent No. 1068699 discloses a composition having antioxidant activity containing a zinnia mushroom extract. It is different from the zinnia mushroom extract in which the functional ingredient of the invention is enhanced.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명의 목적은 베타글루칸 함량이 풍부한 꽃송이버섯을 이용하여 기능성 성분 함량을 증진시키고 기호도가 우수한 꽃송이버섯 추출물을 제조하는 데 있다.The present invention has been derived from the above needs, and an object of the present invention is to improve the content of functional components and prepare a mushroom extract having excellent palatability using a mushroom mushroom rich in beta-glucan content.
상기 과제를 해결하기 위해, 본 발명은 (1) 속단에 물을 첨가하고 추출한 후 여과하여 속단 추출액을 제조하는 단계; (2) 여뀌잎에 물을 첨가하고 추출한 후 여과하여 여뀌 추출액을 제조하는 단계; (3) 꽃송이버섯에 상기 (1)단계의 제조한 속단 추출액을 분무하는 단계; (4) 상기 (3)단계의 분무한 꽃송이버섯을 건조하는 단계; (5) 상기 (4)단계의 건조한 꽃송이버섯에 상기 (2)단계의 제조한 여뀌 추출액을 분무하는 단계; (6) 상기 (5)단계의 분무한 꽃송이버섯을 건조하는 단계; 및 (7) 상기 (6)단계의 건조한 꽃송이버섯에 물을 첨가한 후 추출하는 단계를 포함하여 제조하는 것을 특징으로 하는 꽃송이버섯 추출물의 제조방법을 제공한다.In order to solve the above problems, the present invention comprises the steps of (1) preparing a quick-stage extract by adding water to the quick-stage, extracting and then filtering; (2) adding water to the leaves, extracting them, and then filtering to prepare an extract; (3) spraying the quick-release extract prepared in step (1) on the zinnia mushroom; (4) drying the sprayed zinnia mushroom of step (3); (5) spraying the dried zinnia extract prepared in step (2) on the dried zinnia mushroom in step (4); (6) drying the sprayed zinnia mushroom of step (5); and (7) adding water to the dried zinnia mushroom in step (6) and then extracting it to provide a method for producing a zinnia mushroom extract, characterized in that it is produced.
또한, 본 발명은 상기 방법으로 제조된 꽃송이버섯 추출물을 제공한다.In addition, the present invention provides a flower mushroom extract prepared by the above method.
본 발명은 꽃송이버섯 특유의 이취는 제거되면서 꽃송이버섯에 풍부한 베타글루칸 함량을 더욱 증진시키면서, 섭취가 용이하도록 기호도도 향상시켜, 다양한 가공식품에 유용하게 이용할 수 있는 효과가 있다.The present invention has an effect that can be usefully used in various processed foods by improving the taste for easy intake while further enhancing the content of beta-glucan, which is abundant in the mushroom mushroom, while removing the peculiar odor of the mushroom mushroom.
본 발명의 목적을 달성하기 위하여, 본 발명은In order to achieve the object of the present invention, the present invention
(1) 속단에 물을 첨가하고 추출한 후 여과하여 속단 추출액을 제조하는 단계;(1) preparing a quick-stage extract by adding water to quick-stage, extracting, and filtering;
(2) 여뀌잎에 물을 첨가하고 추출한 후 여과하여 여뀌 추출액을 제조하는 단계;(2) adding water to the leaves, extracting them, and then filtering to prepare an extract;
(3) 꽃송이버섯에 상기 (1)단계의 제조한 속단 추출액을 분무하는 단계;(3) spraying the quick-release extract prepared in step (1) on the zinnia mushroom;
(4) 상기 (3)단계의 분무한 꽃송이버섯을 건조하는 단계;(4) drying the sprayed zinnia mushroom of step (3);
(5) 상기 (4)단계의 건조한 꽃송이버섯에 상기 (2)단계의 제조한 여뀌 추출액을 분무하는 단계;(5) spraying the dried zinnia extract prepared in step (2) on the dried zinnia mushroom in step (4);
(6) 상기 (5)단계의 분무한 꽃송이버섯을 건조하는 단계; 및(6) drying the sprayed zinnia mushroom of step (5); and
(7) 상기 (6)단계의 건조한 꽃송이버섯에 물을 첨가한 후 추출하는 단계를 포함하여 제조하는 것을 특징으로 하는 꽃송이버섯 추출물의 제조방법을 제공한다.(7) It provides a method for producing a mushroom extract characterized in that it is prepared by adding water to the dried mushroom mushroom in step (6) and then extracting it.
본 발명의 꽃송이버섯 추출물의 제조방법에서, 상기 (1)단계의 속단 추출액은 바람직하게는 속단 80~120 g에 물 0.8~1.2 L를 첨가한 후 80~100℃에서 20~40분 동안 추출한 후 여과하여 제조할 수 있으며, 더욱 바람직하게는 속단 100 g에 물 1 L를 첨가한 후 90℃에서 30분 동안 추출한 후 여과하여 제조할 수 있다.In the method for producing the zinnia mushroom extract of the present invention, the quick-stage extract in step (1) is preferably extracted at 80-100 ° C. for 20-40 minutes after adding 0.8-1.2 L of water to 80-120 g of rapid-stage. It can be prepared by filtration, more preferably by adding 1 L of water to 100 g of rapid cutting, followed by extraction at 90 ° C. for 30 minutes and then filtration.
또한, 본 발명의 꽃송이버섯 추출물의 제조방법에서, 상기 (2)단계의 여뀌 추출액은 바람직하게는 여뀌잎 80~120 g에 물 1.8~2.2 L를 첨가한 후 60~80℃에서 2~4시간 동안 추출한 후 여과하여 제조할 수 있으며, 더욱 바람직하게는 여뀌잎 100 g에 물 2 L를 첨가한 후 70℃에서 3시간 동안 추출한 후 여과하여 제조할 수 있다.In addition, in the manufacturing method of the zinnia mushroom extract of the present invention, the fermented persimmon extract in step (2) is preferably added to 80 to 120 g of persimmon leaves with 1.8 to 2.2 L of water, followed by 2 to 4 hours at 60 to 80 ° C. It can be prepared by filtering after extraction for a period of time, more preferably by adding 2 L of water to 100 g of Korean cabbage leaves, extracting at 70 ° C. for 3 hours, and then filtering.
또한, 본 발명의 꽃송이버섯 추출물의 제조방법에서, 상기 (3)단계는 바람직하게는 꽃송이버섯에 속단 추출액을 8.8~9.2:0.8~1.2(w:v) 비율로 분무할 수 있으며, 더욱 바람직하게는 꽃송이버섯에 속단 추출액을 9:1(w:v) 비율로 분무할 수 있다.In addition, in the method for producing the zinnia mushroom extract of the present invention, the step (3) may preferably spray the zinnia mushroom with the rapid stage extract at a ratio of 8.8 to 9.2: 0.8 to 1.2 (w: v), more preferably can be sprayed with cauliflower mushroom at a ratio of 9:1 (w:v).
또한, 본 발명의 꽃송이버섯 추출물의 제조방법에서, 상기 (4)단계는 바람직하게는 분무한 꽃송이버섯을 20~30℃에서 1~3일 동안 건조할 수 있으며, 더욱 바람직하게는 분무한 꽃송이버섯을 20~30℃에서 2일 동안 건조할 수 있다.In addition, in the method for producing the zinnia mushroom extract of the present invention, the step (4) may preferably dry the sprayed zinnia mushroom at 20 to 30 ° C. for 1 to 3 days, more preferably the sprayed zinnia mushroom. can be dried for 2 days at 20-30 ° C.
또한, 본 발명의 꽃송이버섯 추출물의 제조방법에서, 상기 (5)단계는 바람직하게는 건조한 꽃송이버섯에 여뀌 추출액을 8.8~9.2:0.8~1.2(w:v) 비율로 분무할 수 있으며, 더욱 바람직하게는 건조한 꽃송이버섯에 여뀌 추출액을 9:1(w:v) 비율로 분무할 수 있다.In addition, in the method for producing the zinnia mushroom extract of the present invention, in the step (5), the extract may be preferably sprayed on the dried zinnia mushroom at a ratio of 8.8 to 9.2: 0.8 to 1.2 (w: v), more preferably Preferably, the dried zinnia mushroom can be sprayed with the yeokyun extract at a ratio of 9:1 (w:v).
또한, 본 발명의 꽃송이버섯 추출물의 제조방법에서, 상기 (6)단계는 바람직하게는 분무한 꽃송이버섯을 20~30℃에서 1~3일 동안 건조할 수 있으며, 더욱 바람직하게는 분무한 꽃송이버섯을 20~30℃에서 2일 동안 건조할 수 있다.In addition, in the method for producing the zinnia mushroom extract of the present invention, step (6) may preferably dry the sprayed zinnia mushroom at 20 to 30 ° C. for 1 to 3 days, more preferably the sprayed zinnia mushroom. can be dried for 2 days at 20-30 ° C.
또한, 본 발명의 꽃송이버섯 추출물의 제조방법에서, 상기 (7)단계는 바람직하게는 건조한 꽃송이버섯에 꽃송이버섯 대비 물 8~12배(v/w) 첨가한 후 80~100℃에서 50~70분 동안 추출할 수 있으며, 더욱 바람직하게는 건조한 꽃송이버섯에 꽃송이버섯 대비 물 10배(v/w) 첨가한 후 90℃에서 60분 동안 추출할 수 있다.In addition, in the manufacturing method of the zinnia mushroom extract of the present invention, the step (7) is preferably 8 to 12 times (v / w) of water compared to the zinnia mushroom added to the dried zinnia mushroom, and then 50 to 70 °C at 80 ~ 100 ° C. It can be extracted for minutes, more preferably, it can be extracted for 60 minutes at 90 ° C. after adding 10 times (v / w) of water compared to blossom mushrooms to dried blossom mushrooms.
본 발명의 꽃송이버섯 추출물의 제조방법은, 보다 구체적으로는The method for producing the zinnia mushroom extract of the present invention is more specifically
(1) 속단 80~120 g에 물 0.8~1.2 L를 첨가한 후 80~100℃에서 20~40분 동안 추출한 후 여과하여 속단 추출액을 제조하는 단계;(1) adding 0.8 to 1.2 L of water to 80 to 120 g of rapid stage, followed by extraction at 80 to 100 ° C. for 20 to 40 minutes, followed by filtration to prepare a rapid stage extract;
(2) 여뀌잎 80~120 g에 물 1.8~2.2 L를 첨가한 후 60~80℃에서 2~4시간 동안 추출한 후 여과하여 여뀌 추출액을 제조하는 단계;(2) adding 1.8 to 2.2 L of water to 80 to 120 g of saffron leaves, extracting at 60 to 80 ° C. for 2 to 4 hours, and then filtering to prepare a saffron extract;
(3) 꽃송이버섯에 상기 (1)단계의 제조한 속단 추출액을 8.8~9.2:0.8~1.2(w:v) 비율로 분무하는 단계;(3) spraying the mushroom extract prepared in step (1) at a ratio of 8.8 to 9.2:0.8 to 1.2 (w:v);
(4) 상기 (3)단계의 분무한 꽃송이버섯을 20~30℃에서 1~3일 동안 건조하는 단계;(4) drying the sprayed zinnia mushroom of step (3) at 20-30 ° C for 1-3 days;
(5) 상기 (4)단계의 건조한 꽃송이버섯에 상기 (2)단계의 제조한 여뀌 추출액을 8.8~9.2:0.8~1.2(w:v) 비율로 분무하는 단계;(5) spraying the dried cauliflower mushroom in step (4) with the extract prepared in step (2) at a ratio of 8.8 to 9.2:0.8 to 1.2 (w:v);
(6) 상기 (5)단계의 분무한 꽃송이버섯을 20~30℃에서 1~3일 동안 건조하는 단계; 및(6) drying the sprayed zinnia mushroom of step (5) at 20-30 ° C for 1-3 days; and
(7) 상기 (6)단계의 건조한 꽃송이버섯에 꽃송이버섯 대비 물 8~12배(v/w) 첨가한 후 80~100℃에서 50~70분 동안 추출하는 단계를 포함할 수 있으며,(7) adding 8 to 12 times (v/w) of water compared to the zinnia mushroom to the dried zinnia mushroom in step (6) and then extracting at 80 to 100 ° C. for 50 to 70 minutes,
더욱 구체적으로는more specifically
(1) 속단 100 g에 물 1 L를 첨가한 후 90℃에서 30분 동안 추출한 후 여과하여 속단 추출액을 제조하는 단계;(1) adding 1 L of water to 100 g of rapid stage, followed by extraction at 90° C. for 30 minutes, followed by filtration to prepare a rapid stage extract;
(2) 여뀌잎 100 g에 물 2 L를 첨가한 후 70℃에서 3시간 동안 추출한 후 여과하여 여뀌 추출액을 제조하는 단계;(2) adding 2 L of water to 100 g of Yeo Kyun leaves, extracting at 70 ° C. for 3 hours, and then filtering to prepare a Yeo Kwi extract;
(3) 꽃송이버섯에 상기 (1)단계의 제조한 속단 추출액을 9:1(w:v) 비율로 분무하는 단계;(3) spraying the mushroom extract prepared in step (1) at a ratio of 9: 1 (w: v);
(4) 상기 (3)단계의 분무한 꽃송이버섯을 20~30℃에서 2일 동안 건조하는 단계;(4) drying the sprayed zinnia mushroom of step (3) at 20 to 30 ° C for 2 days;
(5) 상기 (4)단계의 건조한 꽃송이버섯에 상기 (2)단계의 제조한 여뀌 추출액을 9:1(w:v) 비율로 분무하는 단계;(5) spraying the dried zinnia extract prepared in step (2) at a ratio of 9:1 (w:v) to the dried zinnia mushroom in step (4);
(6) 상기 (5)단계의 분무한 꽃송이버섯을 20~30℃에서 2일 동안 건조하는 단계; 및(6) drying the sprayed zinnia mushroom of step (5) at 20 to 30 ° C for 2 days; and
(7) 상기 (6)단계의 건조한 꽃송이버섯에 꽃송이버섯 대비 물 10배(v/w) 첨가한 후 90℃에서 60분 동안 추출하는 단계를 포함할 수 있다.(7) adding 10 times (v/w) of water to the dried zinnia mushroom in step (6) and then extracting at 90° C. for 60 minutes.
본 발명의 또한, 상기 방법으로 제조된 꽃송이버섯 추출물을 제공한다.The present invention also provides a flower mushroom extract prepared by the above method.
본 발명은 또한, 상기 꽃송이버섯 추출물을 함유하는 가공식품을 제공한다. 상기 가공식품의 종류에는 특별한 제한은 없다. 상기 꽃송이버섯 추출물을 첨가할 수 있는 식품의 예로는 육류, 소세지, 빵, 쵸코렛, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 떡류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 가공식품을 모두 포함한다.The present invention also provides a processed food containing the zinnia mushroom extract. There is no particular limitation on the type of the processed food. Examples of foods to which the zinnia mushroom extract can be added include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gum, rice cakes, dairy products including ice cream, various soups, beverages, There are tea, drinks, alcoholic beverages and vitamin complexes, etc., and includes all processed foods in a conventional sense.
이하, 본 발명의 제조예 및 실시예를 들어 상세히 설명한다. 단, 하기 제조예 및 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 제조예 및 실시예에 한정되는 것은 아니다.Hereinafter, production examples and examples of the present invention will be described in detail. However, the following Preparation Examples and Examples are only to illustrate the present invention, and the content of the present invention is not limited to the following Preparation Examples and Examples.
제조예 1. 꽃송이버섯 추출물Preparation Example 1. Zinnia mushroom extract
(1) 속단(Phlomis umbrosa) 100 g에 정제수 1 L를 첨가한 후 90℃에서 30분 동안 추출한 후 여과하여 속단 추출액을 제조하였다.(1) Sokdan ( Phlomis umbrosa ) After adding 1 L of purified water to 100 g, extraction was performed at 90 ° C. for 30 minutes, followed by filtration to prepare a rapid-stage extract.
(2) 여뀌잎 100 g에 정제수 2 L를 첨가한 후 70℃에서 3시간 동안 추출한 후 여과하여 여뀌 추출액을 제조하였다.(2) After adding 2 L of purified water to 100 g of Yeo Kyun leaves, extracting at 70 ° C. for 3 hours, and then filtering to prepare Yeo Kyun extract.
(3) 꽃송이버섯에 상기 (1)단계의 제조한 속단 추출액을 9:1(w:v) 비율로 골고루 분무하였다.(3) The quick-release extract prepared in step (1) was evenly sprayed on the zinnia mushroom at a ratio of 9: 1 (w: v).
(4) 상기 (3)단계의 분무한 꽃송이버섯을 20~30℃에서 2일 동안 자연건조하였다.(4) The sprayed flower mushrooms in step (3) were naturally dried at 20-30 ° C for 2 days.
(5) 상기 (4)단계의 자연건조한 꽃송이버섯에 상기 (2)단계의 제조한 여뀌 추출액을 9:1(w:v) 비율로 골고루 분무하였다.(5) The naturally dried flower mushroom in step (4) was evenly sprayed with the extract prepared in step (2) at a ratio of 9: 1 (w: v).
(6) 상기 (5)단계의 분무한 꽃송이버섯을 20~30℃에서 2일 동안 자연건조하였다.(6) The sprayed flower mushroom in step (5) was naturally dried at 20-30 ° C for 2 days.
(7) 상기 (6)단계의 자연건조한 꽃송이버섯에 꽃송이버섯 대비 정제수 10배(v/w) 첨가한 후 90℃에서 1시간 동안 추출한 후 여과하였다.(7) 10 times (v/w) of purified water compared to the zinnia mushroom was added to the naturally dried zinnia mushroom in step (6), extracted at 90 ° C. for 1 hour, and then filtered.
비교예 1. 꽃송이버섯 추출물Comparative Example 1. Zinnia mushroom extract
(1) 꽃송이버섯을 20~30℃에서 2일 동안 자연건조하였다.(1) Cauliflower mushrooms were naturally dried at 20-30 ° C for 2 days.
(2) 상기 (1)단계의 자연건조한 꽃송이버섯에 꽃송이버섯 대비 정제수 10배(v/w) 첨가한 후 90℃에서 1시간 동안 추출한 후 여과하였다.(2) 10 times (v/w) of purified water compared to the zinnia mushroom was added to the naturally dried zinnia mushroom in step (1), extracted at 90 ° C. for 1 hour, and then filtered.
비교예 2. 꽃송이버섯 추출물Comparative Example 2. Zinnia mushroom extract
(1) 속단(Phlomis umbrosa) 100 g에 정제수 1 L를 첨가한 후 90℃에서 30분 동안 추출한 후 여과하여 속단 추출액을 제조하였다.(1) Sokdan ( Phlomis umbrosa ) After adding 1 L of purified water to 100 g, extraction was performed at 90 ° C. for 30 minutes, followed by filtration to prepare a rapid-stage extract.
(2) 꽃송이버섯에 상기 (1)단계의 제조한 속단 추출액을 9:1(w:v) 비율로 골고루 분무하였다.(2) The quick-release extract prepared in step (1) was evenly sprayed on the zinnia mushroom at a ratio of 9: 1 (w: v).
(3) 상기 (2)단계의 분무한 꽃송이버섯을 20~30℃에서 2일 동안 자연건조하였다.(3) The sprayed flower mushrooms in step (2) were naturally dried at 20 to 30 ° C for 2 days.
(4) 상기 (3)단계의 자연건조한 꽃송이버섯에 꽃송이버섯 대비 정제수 10배(v/w) 첨가한 후 90℃에서 1시간 동안 추출한 후 여과하였다.(4) After adding 10 times (v/w) of purified water compared to the zinnia mushroom to the naturally dried zinnia mushroom in step (3), extraction was performed at 90 ° C. for 1 hour and filtered.
비교예 3. 꽃송이버섯 추출물Comparative Example 3. Zinnia mushroom extract
(1) 여뀌잎 100 g에 정제수 2 L를 첨가한 후 70℃에서 3시간 동안 추출한 후 여과하여 여뀌 추출액을 제조하였다.(1) After adding 2 L of purified water to 100 g of Yeo Kyun leaves, extracting at 70 ° C. for 3 hours, and then filtering to prepare Yeo Kyun extract.
(2) 꽃송이버섯에 상기 (1)단계의 제조한 여뀌잎 추출액을 9:1(w:v) 비율로 골고루 분무하였다.(2) The mushroom leaf extract prepared in step (1) was evenly sprayed on the flower mushroom at a ratio of 9: 1 (w: v).
(3) 상기 (2)단계의 분무한 꽃송이버섯을 20~30℃에서 2일 동안 자연건조하였다.(3) The sprayed flower mushrooms in step (2) were naturally dried at 20 to 30 ° C for 2 days.
(4) 상기 (3)단계의 자연건조한 꽃송이버섯에 꽃송이버섯 대비 정제수 10배(v/w) 첨가한 후 90℃에서 1시간 동안 추출한 후 여과하였다.(4) After adding 10 times (v/w) of purified water compared to the zinnia mushroom to the naturally dried zinnia mushroom in step (3), extraction was performed at 90 ° C. for 1 hour and filtered.
실험방법Experiment method
1. 베타글루칸(β-glucan) 함량 측정1. Measurement of β-glucan content
(a) 총 글루칸(Total glucan) 분석 전처리: 동결건조한 각 시료 0.1 g씩 캡 튜브에 취하고 12M H2SO4 2 mL를 넣고 캡(cap)을 닫은 뒤 수시로 볼텍싱(vortexing) 해주며 4℃에서 2시간 동안 분해시켰다. 분해가 끝난 시료에 4 mL의 증류수를 조심히 넣은 후 10초 동안 볼텍싱해 준 후 6 mL의 증류수를 첨가하고 10초 동안 추가로 볼텍싱하였다. 그 후 캡(cap)을 살짝 열고 끓는물(100℃)에서 5분 동안 반응시킨 후 뚜껑을 닫고 추가로 2시간 동안 반응시켰다. 반응이 끝난 시료는 실온에서 천천히 식히고 캡을 조심히 연 후 100 mL 정용 플라스크에 취한 후 6 mL의 10M KOH를 넣고 아세트산나트륨 완충액(200 mM, pH 5)으로 정용하였다. 이를 여과한 후 총 글루칸 시험용액으로 사용하였다.(a) Pretreatment for total glucan analysis: 0.1 g of each lyophilized sample was taken in a cap tube, 2 mL of 12M H 2 SO 4 was added, the cap was closed, and the mixture was vortexed from time to time at 4 ° C. Digested for 2 hours. After carefully adding 4 mL of distilled water to the degraded sample and vortexing for 10 seconds, 6 mL of distilled water was added and further vortexing for 10 seconds. After that, the cap was slightly opened and reacted in boiling water (100 ° C.) for 5 minutes, and then the lid was closed and reacted for an additional 2 hours. After the reaction was completed, the sample was slowly cooled at room temperature, the cap was carefully opened, taken into a 100 mL constant-use flask, and 6 mL of 10M KOH was added thereto, followed by sodium acetate buffer (200 mM, pH 5). After filtering, it was used as a total glucan test solution.
(b) α-글루칸 및 유리 글루코스(free glucose) 분석 전처리: 동결건조한 각 시료 0.1 g씩 캡 튜브(cap tube)에 취하고 2M KOH 2 mL를 넣어 교반한 후 20분 동안 4℃에서 정치하였다. 그 후 아세트산나트륨 완충액(1.2M, pH 3.8) 8 mL를 넣고, 보틀 2(Amyloglucosidase (1,630 U/mL) plus invertase (500 U/mL) solution in 50%(v/v) glycerol) 0.2 mL를 넣은 후 40℃에서 30분간 반응시켰다. 그 후 100 mL로 증류수로 정용하고 여과한 후 시험용액으로 사용하였다.(b) Analysis of α-glucan and free glucose Pretreatment: 0.1 g of each lyophilized sample was taken in a cap tube, 2 mL of 2M KOH was added, stirred, and allowed to stand at 4° C. for 20 minutes. Then, 8 mL of sodium acetate buffer (1.2M, pH 3.8) was added, and 0.2 mL of bottle 2 (Amyloglucosidase (1,630 U/mL) plus invertase (500 U/mL) solution in 50% (v/v) glycerol) was added. and then reacted at 40° C. for 30 minutes. Then, 100 mL of distilled water was added, filtered, and used as a test solution.
(c) 총 글루칸 분석: 시험용액 0.1 mL를 채취하고 보틀 1(exo-1,3-β-Glucanase (100 U/mL) plus β-Glucosidase (20 U/mL) ammonium sulphate suspension) 0.1 mL를 취하고 볼텍싱 해준 뒤 40℃에서 60분 동안 반응시켰다. 그 후 3 mL의 GOPOD 시약을 가하고 40℃에서 20분간 반응시킨 후 510 nm에서 흡광도를 측정하였다. 시약 블랭크(reagent blank)로서 0.2 mL 아세트산나트륨 완충액(200 mM, pH 5.0)과 3 mL GOPOD 시약이 사용되었고, 글루코스 표준물질로는 0.1 mL 아세트산나트륨 완충액(200 mM, pH 5.0)과 0.1 mL D-글루코스 스텐다드 용액(1.00 mg/mL in 0.2% benzoic acid)과 3 mL GOPOD 시약이 사용되었다.(c) Total glucan analysis: Take 0.1 mL of test solution and take 0.1 mL of bottle 1 (exo-1,3-β-Glucanase (100 U/mL) plus β-Glucosidase (20 U/mL) ammonium sulphate suspension) After vortexing, the mixture was reacted at 40° C. for 60 minutes. Thereafter, 3 mL of GOPOD reagent was added and reacted at 40° C. for 20 minutes, and then absorbance was measured at 510 nm. As a reagent blank, 0.2 mL sodium acetate buffer (200 mM, pH 5.0) and 3 mL GOPOD reagent were used, and as glucose standards, 0.1 mL sodium acetate buffer (200 mM, pH 5.0) and 0.1 mL D- A glucose standard solution (1.00 mg/mL in 0.2% benzoic acid) and 3 mL GOPOD reagent were used.
(d) α-글루칸 및 유리 글루코스(free glucose) 분석: 시험용액 0.1 mL를 채취하고 0.1 mL 아세트산나트륨 완충액(200 mM, pH 5.0)를 취하고 볼텍싱해 준 뒤 3 mL의 GOPOD 시약을 가하고 40℃에서 20분간 반응시킨 후 510 nm에서 흡광도를 측정하였다. 시약 블랭크(reagent blank)로서 0.2 mL 아세트산나트륨 완충액(200 mM, pH 5.0)과 3 mL GOPOD 시약이 사용되었고, 글루코스 표준물질로는 0.1 mL 아세트산나트륨 완충액(200 mM, pH 5.0)과 0.1 mL D-글루코스 스텐다드 용액(1.00 mg/mL in 0.2% benzoic acid)과 3 mL GOPOD 시약이 사용되었다.(d) Analysis of α-glucan and free glucose: 0.1 mL of the test solution was taken, 0.1 mL of sodium acetate buffer (200 mM, pH 5.0) was vortexed, 3 mL of GOPOD reagent was added, and 40 ° C. After reacting for 20 minutes, absorbance was measured at 510 nm. As a reagent blank, 0.2 mL sodium acetate buffer (200 mM, pH 5.0) and 3 mL GOPOD reagent were used, and as glucose standards, 0.1 mL sodium acetate buffer (200 mM, pH 5.0) and 0.1 mL D- A glucose standard solution (1.00 mg/mL in 0.2% benzoic acid) and 3 mL GOPOD reagent were used.
2. 항염증 활성2. Anti-inflammatory activity
(a) Raw 264.7 대식세포주 전처리(a) Raw 264.7 macrophage cell line pre-treatment
쥐의 대식세포인 Raw 264.7 세포를 이용하여 실험을 진행하였다. Raw 264.7 세포를 10% FBS와 1% 항생제(penicillin/streptomycin)가 첨가된 DMEM 배지를 이용하여 배양하였으며, 컨플루언트(confluent)가 되기 전에 계대 배양하여 실험에 사용하였다.Experiments were conducted using rat macrophage Raw 264.7 cells. Raw 264.7 cells were cultured using DMEM medium supplemented with 10% FBS and 1% antibiotics (penicillin/streptomycin), and were subcultured before reaching confluent and used for experiments.
(b) Raw 264.7 대식세포주의 생존률 평가(b) Evaluation of viability of Raw 264.7 macrophage cell line
Raw 264.7 세포의 시료에 대한 세포 생존률은 cell counting kit-8을 이용하여 독성을 조사하고 이를 통해 항염증 평가에 사용할 시료의 농도를 결정하였다. 배양중인 Raw 264.7 세포를 96 웰 플레이트에 5×104 cells/mL로 접종(seeding)하여 37℃ 온도 및 5% CO2 인큐베이터에서 24시간 배양한 후 시료를 일정한 농도로 희석하여 처리하였다. 이를 48시간 동안 배양한 후 배지를 모두 제거하고 PBS 100 ㎕와 cck-8 시약 10 ㎕를 첨가하여 2시간 동안 암실의 37℃ 및 5% CO2 인큐베이터에서 반응시켰다. 발색된 각 웰을 마이크로플레이트 리더를 이용하여 450 nm에서 흡광도를 측정하였고, 세포 생존율은 다음의 식을 이용하여 확인하였다.The cell viability of Raw 264.7 cell samples was examined for toxicity using cell counting kit-8, and the concentration of the sample to be used for anti-inflammatory evaluation was determined through this. Raw 264.7 cells in culture were seeded in a 96-well plate at 5×10 4 cells/mL, cultured for 24 hours in an incubator at 37° C. and 5% CO 2 , and samples were then diluted to a certain concentration and treated. After incubation for 48 hours, the medium was removed, and 100 μl of PBS and 10 μl of cck-8 reagent were added thereto, followed by reaction in a dark room at 37° C. and 5% CO 2 incubator for 2 hours. The absorbance of each well developed was measured at 450 nm using a microplate reader, and the cell viability was confirmed using the following formula.
세포 생존율(%) = 시료 흡광도/대조구 흡광도 × 100Cell viability (%) = sample absorbance/control absorbance × 100
(c) NO(Nitric oxide) 생성량 비교(c) Comparison of production of NO (Nitric oxide)
Raw 264.7 세포로부터 생성된 NO의 양은 NO2의 형태로서 그리스 시약을 사용하여 측정하였다. 배양 중인 Raw 264.7 세포를 96 웰 플레이트에 5×105 cells/mL로 접종(seeding)하여 37℃ 및 5% CO2 인큐베이터에서 24시간 배양한 후 세포 생존률이 80% 이상 유지된 희석배수로 처리하고 LPS(1 ㎍/mL)를 첨가한 실험구와 비첨가구를 나누어 24시간까지 배양하였다. 배양 후 배양상등액 100 ㎕를 취해 그리스 시약 100 ㎕와 혼합하여 실온에서 10분간 반응시켰다. 반응 후 마이크로플레이트 리더를 이용하여 540 nm에서 흡광도를 측정하였고, 아질산나트륨(NaNO2)을 표준물질로 하여 uM 아질산염(nitrite)로 NO 생성량을 측정하였다.The amount of NO produced from Raw 264.7 cells was measured using Grease reagent in the form of NO 2 . Raw 264.7 cells in culture were seeded in a 96-well plate at 5×10 5 cells/mL, cultured in an incubator at 37° C. and 5% CO 2 for 24 hours, and then treated with a dilution factor that maintained a cell viability of 80% or more and LPS. (1 μg/mL) was divided into experimental groups and non-added groups and cultured for up to 24 hours. After incubation, 100 μl of the culture supernatant was mixed with 100 μl of grease reagent and allowed to react at room temperature for 10 minutes. After the reaction, absorbance was measured at 540 nm using a microplate reader, and NO production was measured with uM nitrite using sodium nitrite (NaNO 2 ) as a standard material.
실시예 1. β-글루칸 함량Example 1. β-glucan content
글루칸(Glucan)은 다당체(polysaccharides)로 버섯류 및 곡류의 보리, 귀리, 호밀 등에 많이 함유되어 있다. 항암효과가 뛰어나지만 암세포를 직접 죽이지는 않고 면역을 높여 암세포의 활동을 억제시키고, T세포 등 면역기능과 관련된 세포의 수와 활성을 높여주는 일종의 면역요법제라고 할 수 있다. 또한 β-글루칸은 버섯류, 효모의 세포벽, 곡류, 곰팡이류 등에 많이 함유되어 있는 다당류의 일종이다. 꽃송이버섯 추출물의 베타글루칸 함량을 측정한 결과는 하기 표 1과 같다.Glucan is a polysaccharides and is contained in a large amount in mushrooms and grains such as barley, oats, and rye. Although it has excellent anticancer effects, it does not directly kill cancer cells, but increases immunity, suppresses the activity of cancer cells, and increases the number and activity of cells related to immune function, such as T cells. In addition, β-glucan is a type of polysaccharide that is abundantly contained in mushrooms, cell walls of yeast, grains, and fungi. The results of measuring the beta-glucan content of the zinnia mushroom extract are shown in Table 1 below.
그 결과, 제조예 1의 방법으로 추출한 꽃송이버섯 추출물이 β-글루칸 함량이 가장 높게 나타남을 확인하였다.As a result, it was confirmed that the zinnia mushroom extract extracted by the method of Preparation Example 1 had the highest β-glucan content.
실시예 2. 항염증 활성Example 2. Anti-inflammatory activity
1. 세포생존율1. Cell viability
RAW 264.7 대식세포의 세포생존율을 평가한 결과, 1 mg/mL 농도의 4개 시료 모두 95% 이상의 생존율을 확인할 수 있었다(표 2). 따라서 1 mg/mL의 농도로 제조하여 다음 실험을 진행하였다.As a result of evaluating the cell viability of RAW 264.7 macrophages, all four samples at a concentration of 1 mg/mL showed a viability of 95% or higher (Table 2). Therefore, it was prepared at a concentration of 1 mg/mL and the following experiment was conducted.
2. 대식세포 NO(nitric oxide) 생성량2. Macrophage NO (nitric oxide) production
면역 활성 등의 역할을 하는 NO(nitric oxide)는 무기 저분자 라디칼로서 신경 전달기능, 혈액응고 및 혈압조절기능, 암세포에 대항하는 면역기능 등의 역할이 알려져 있으며, NOS(nitricoxidesynthase)에 의해 L-아르기닌으로부터 합성된다. 특히, 대식세포(macrophase)는 생체 내에서 염증 등의 자극에 의해 NO(nitric oxide)를 생성하여 항염, 항종양 등의 면역 활성에 중요한 역할을 하게 된다.NO (nitric oxide), which plays a role in immune activity, is an inorganic low-molecular-weight radical, and is known to play a role in nerve transmission, blood coagulation and blood pressure control, and immune function against cancer cells. synthesized from In particular, macrophages (macrophase) produce NO (nitric oxide) by stimuli such as inflammation in vivo to play an important role in immune activity such as anti-inflammatory and anti-tumor.
면역세포를 이용하여 염증 유발 물질로 주로 사용되는 LPS(Lipopoly saccharide)를 1 ㎍/mL를 사용하여 염증을 유발시켰으며 Raw 264.7의 세포에서 생성되는 NO 산화물인 NO2 -(nitrite)를 그리스 시약과 반응 발색시켜 대식세포의 생성정도를 나타내었다. LPS 처리군에서는 NO 생성량이 증가하였으나, 시료를 1 mg/mL의 농도로 희석하여 처리하였을 때 NO 생성량이 감소하였고, 추출물 중에서는 제조예 1의 추출물이 가장 많이 감소하였다. Inflammation was induced using 1 μg/mL of LPS (Lipopoly saccharide), which is mainly used as an inflammation-inducing substance, using immune cells, and NO 2 - (nitrite), a NO oxide generated from the cells of Raw 264.7, was mixed with a grease reagent. The reaction color was developed to indicate the degree of macrophage generation. In the LPS treatment group, the amount of NO production increased, but when the sample was diluted and treated at a concentration of 1 mg/mL, the amount of NO production decreased, and among the extracts, the extract of Preparation Example 1 decreased the most.
Claims (5)
(2) 여뀌잎에 물을 첨가하고 추출한 후 여과하여 여뀌 추출액을 제조하는 단계;
(3) 꽃송이버섯에 상기 (1)단계의 제조한 속단 추출액을 분무하는 단계;
(4) 상기 (3)단계의 분무한 꽃송이버섯을 건조하는 단계;
(5) 상기 (4)단계의 건조한 꽃송이버섯에 상기 (2)단계의 제조한 여뀌 추출액을 분무하는 단계;
(6) 상기 (5)단계의 분무한 꽃송이버섯을 건조하는 단계; 및
(7) 상기 (6)단계의 건조한 꽃송이버섯에 물을 첨가한 후 추출하는 단계를 포함하여 제조하는 것을 특징으로 하는 꽃송이버섯 추출물의 제조방법.(1) preparing a quick-stage extract by adding water to quick-stage, extracting, and filtering;
(2) adding water to the leaves, extracting them, and then filtering to prepare an extract;
(3) spraying the quick-release extract prepared in step (1) on the zinnia mushroom;
(4) drying the sprayed cauliflower mushroom of step (3);
(5) spraying the dried zinnia extract prepared in step (2) on the dried zinnia mushroom in step (4);
(6) drying the sprayed zinnia mushroom of step (5); and
(7) A method for producing a zinnia mushroom extract, characterized in that it is prepared by adding water to the dried zinnia mushroom in step (6) and then extracting it.
(1) 속단 80~120 g에 물 0.8~1.2 L를 첨가한 후 80~100℃에서 20~40분 동안 추출한 후 여과하여 속단 추출액을 제조하는 단계;
(2) 여뀌잎 80~120 g에 물 1.8~2.2 L를 첨가한 후 60~80℃에서 2~4시간 동안 추출한 후 여과하여 여뀌 추출액을 제조하는 단계;
(3) 꽃송이버섯에 상기 (1)단계의 제조한 속단 추출액을 분무하는 단계;
(4) 상기 (3)단계의 분무한 꽃송이버섯을 건조하는 단계;
(5) 상기 (4)단계의 건조한 꽃송이버섯에 상기 (2)단계의 제조한 여뀌 추출액을 분무하는 단계;
(6) 상기 (5)단계의 분무한 꽃송이버섯을 건조하는 단계; 및
(7) 상기 (6)단계의 건조한 꽃송이버섯에 물을 첨가한 후 추출하는 단계를 포함하여 제조하는 것을 특징으로 하는 꽃송이버섯 추출물의 제조방법.According to claim 1,
(1) adding 0.8 to 1.2 L of water to 80 to 120 g of rapid stage, followed by extraction at 80 to 100 ° C. for 20 to 40 minutes, followed by filtration to prepare a rapid stage extract;
(2) adding 1.8 to 2.2 L of water to 80 to 120 g of saffron leaves, extracting at 60 to 80 ° C. for 2 to 4 hours, and then filtering to prepare a saffron extract;
(3) spraying the quick-release extract prepared in step (1) on the zinnia mushroom;
(4) drying the sprayed zinnia mushroom of step (3);
(5) spraying the dried zinnia extract prepared in step (2) on the dried zinnia mushroom in step (4);
(6) drying the sprayed zinnia mushroom of step (5); and
(7) A method for producing a zinnia mushroom extract, characterized in that it is prepared by adding water to the dried zinnia mushroom in step (6) and then extracting it.
(1) 속단 80~120 g에 물 0.8~1.2 L를 첨가한 후 80~100℃에서 20~40분 동안 추출한 후 여과하여 속단 추출액을 제조하는 단계;
(2) 여뀌잎 80~120 g에 물 1.8~2.2 L를 첨가한 후 60~80℃에서 2~4시간 동안 추출한 후 여과하여 여뀌 추출액을 제조하는 단계;
(3) 꽃송이버섯에 상기 (1)단계의 제조한 속단 추출액을 8.8~9.2:0.8~1.2(w:v) 비율로 분무하는 단계;
(4) 상기 (3)단계의 분무한 꽃송이버섯을 건조하는 단계;
(5) 상기 (4)단계의 건조한 꽃송이버섯에 상기 (2)단계의 제조한 여뀌 추출액을 8.8~9.2:0.8~1.2(w:v) 비율로 분무하는 단계;
(6) 상기 (5)단계의 분무한 꽃송이버섯을 건조하는 단계; 및
(7) 상기 (6)단계의 건조한 꽃송이버섯에 꽃송이버섯 대비 물 8~12배(v/w) 첨가한 후 추출하는 단계를 포함하여 제조하는 것을 특징으로 하는 꽃송이버섯 추출물의 제조방법.According to claim 2,
(1) adding 0.8 to 1.2 L of water to 80 to 120 g of rapid stage, followed by extraction at 80 to 100 ° C. for 20 to 40 minutes, followed by filtration to prepare a rapid stage extract;
(2) adding 1.8 to 2.2 L of water to 80 to 120 g of saffron leaves, extracting at 60 to 80 ° C. for 2 to 4 hours, and then filtering to prepare a saffron extract;
(3) spraying the mushroom extract prepared in step (1) at a ratio of 8.8 to 9.2:0.8 to 1.2 (w:v);
(4) drying the sprayed zinnia mushroom of step (3);
(5) spraying the dried cauliflower mushroom in step (4) with the extract prepared in step (2) at a ratio of 8.8 to 9.2:0.8 to 1.2 (w:v);
(6) drying the sprayed zinnia mushroom of step (5); and
(7) A method for producing a zinnia mushroom extract, characterized in that it is prepared by adding 8 to 12 times (v / w) of water compared to the zinnia mushroom to the dried zinnia mushroom in step (6) and then extracting.
(1) 속단 80~120 g에 물 0.8~1.2 L를 첨가한 후 80~100℃에서 20~40분 동안 추출한 후 여과하여 속단 추출액을 제조하는 단계;
(2) 여뀌잎 80~120 g에 물 1.8~2.2 L를 첨가한 후 60~80℃에서 2~4시간 동안 추출한 후 여과하여 여뀌 추출액을 제조하는 단계;
(3) 꽃송이버섯에 상기 (1)단계의 제조한 속단 추출액을 8.8~9.2:0.8~1.2(w:v) 비율로 분무하는 단계;
(4) 상기 (3)단계의 분무한 꽃송이버섯을 20~30℃에서 1~3일 동안 건조하는 단계;
(5) 상기 (4)단계의 건조한 꽃송이버섯에 상기 (2)단계의 제조한 여뀌 추출액을 8.8~9.2:0.8~1.2(w:v) 비율로 분무하는 단계;
(6) 상기 (5)단계의 분무한 꽃송이버섯을 20~30℃에서 1~3일 동안 건조하는 단계; 및
(7) 상기 (6)단계의 건조한 꽃송이버섯에 꽃송이버섯 대비 물 8~12배(v/w) 첨가한 후 80~100℃에서 50~70분 동안 추출하는 단계를 포함하여 제조하는 것을 특징으로 하는 꽃송이버섯 추출물의 제조방법.According to claim 3,
(1) adding 0.8 to 1.2 L of water to 80 to 120 g of rapid stage, followed by extraction at 80 to 100 ° C. for 20 to 40 minutes, followed by filtration to prepare a rapid stage extract;
(2) adding 1.8 to 2.2 L of water to 80 to 120 g of saffron leaves, extracting at 60 to 80 ° C. for 2 to 4 hours, and then filtering to prepare a saffron extract;
(3) spraying the mushroom extract prepared in step (1) at a ratio of 8.8 to 9.2:0.8 to 1.2 (w:v);
(4) drying the sprayed zinnia mushroom of step (3) at 20-30 ° C for 1-3 days;
(5) spraying the dried cauliflower mushroom in step (4) with the extract prepared in step (2) at a ratio of 8.8 to 9.2:0.8 to 1.2 (w:v);
(6) drying the sprayed zinnia mushroom of step (5) at 20-30 ° C for 1-3 days; and
(7) It is characterized in that it is prepared by adding 8 to 12 times (v / w) of water compared to the zinnia mushroom to the dried zinnia mushroom in step (6) and then extracting at 80 to 100 ° C. for 50 to 70 minutes Method for producing a flower mushroom extract to do.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210155636A KR102483343B1 (en) | 2021-11-12 | 2021-11-12 | Sparassis crispa extract with enhanced functional components |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210155636A KR102483343B1 (en) | 2021-11-12 | 2021-11-12 | Sparassis crispa extract with enhanced functional components |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102483343B1 true KR102483343B1 (en) | 2022-12-30 |
Family
ID=84538861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210155636A KR102483343B1 (en) | 2021-11-12 | 2021-11-12 | Sparassis crispa extract with enhanced functional components |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102483343B1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110017553A (en) * | 2009-08-14 | 2011-02-22 | 홍상근 | The white pleuropterus multiflorus extracts and phlomis umbrosa extracts for spuring of insulin-like growth factor secretion and bony framework growth and the manufacturing method thereof |
KR20110130131A (en) * | 2010-05-27 | 2011-12-05 | 이수제약(주) | Antimicrobial composition containing p. nepalensis and p. japonica extracts |
KR20160105730A (en) * | 2016-08-18 | 2016-09-07 | 주식회사 더진 | Lactic acid-coated mushrooms |
KR101783912B1 (en) * | 2017-07-06 | 2017-10-16 | (주)신성농산 | Manufacturing method of coloring fermented shiitake mushroom comprising natural fermented compositions and coloring fermented shiitake mushroom by the method |
KR20200013858A (en) * | 2018-07-31 | 2020-02-10 | 농업회사법인 주식회사 아람 | Manufacturing method of sparassis crispa extract |
KR20210063645A (en) * | 2019-11-25 | 2021-06-02 | 안보미 | Beverage manufacturing method using sparassis crispa and beverage thereof |
-
2021
- 2021-11-12 KR KR1020210155636A patent/KR102483343B1/en active IP Right Grant
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110017553A (en) * | 2009-08-14 | 2011-02-22 | 홍상근 | The white pleuropterus multiflorus extracts and phlomis umbrosa extracts for spuring of insulin-like growth factor secretion and bony framework growth and the manufacturing method thereof |
KR20110130131A (en) * | 2010-05-27 | 2011-12-05 | 이수제약(주) | Antimicrobial composition containing p. nepalensis and p. japonica extracts |
KR20160105730A (en) * | 2016-08-18 | 2016-09-07 | 주식회사 더진 | Lactic acid-coated mushrooms |
KR101783912B1 (en) * | 2017-07-06 | 2017-10-16 | (주)신성농산 | Manufacturing method of coloring fermented shiitake mushroom comprising natural fermented compositions and coloring fermented shiitake mushroom by the method |
KR20200013858A (en) * | 2018-07-31 | 2020-02-10 | 농업회사법인 주식회사 아람 | Manufacturing method of sparassis crispa extract |
KR20210063645A (en) * | 2019-11-25 | 2021-06-02 | 안보미 | Beverage manufacturing method using sparassis crispa and beverage thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101544941B (en) | Waxberry wine and brewing method thereof | |
KR101911771B1 (en) | Mixed Fermented Material of Extraction of Oriental Medicine Material With Higher γ-PGA and GABA for Enhancing Immune Activity or Inhibiting Allergy and Method for Manufacturing the Same | |
KR102387371B1 (en) | Fermented Stauntonia hexaphylla with improved antioxidant activity and uses thereof | |
WA et al. | Bioactive potential of some fascinating edible mushrooms Macrolepiota, Russula, Amanita, Vovariella and Grifola as a treasure of multipurpose therapeutic natural product | |
CN113293074A (en) | Dragon-flavor liquor based on specially-made distiller's yeast and production process thereof | |
KR101508362B1 (en) | Method for producing functional soybean paste using seaweed | |
KR102050655B1 (en) | Method for producing fermented apple and pear using Lentinus edodes mycelium | |
KR102483343B1 (en) | Sparassis crispa extract with enhanced functional components | |
KR101874330B1 (en) | Production method of fermentation vinegar using balloon flower | |
KR100663876B1 (en) | Culture of mushroom mycellia having physiologically active effect | |
KR20120132207A (en) | Pharmaceutical compositions for the treatment of diabetes mellitus and obesity comprising the extract of mushroom mycelial rice | |
KR101816539B1 (en) | Raw rice wine containing ginseng berry extracts | |
KR20090129277A (en) | Laver containing green tea and manufacturing method thereof | |
RU2466542C1 (en) | Method for enhancement of bakery goods quality and goods freshness preservation using "yagel-t" solidphase food additive | |
CN113068842A (en) | Preparation method of pear dietary fiber | |
KR20040005351A (en) | Fermentation liquor of houttuynia cordata and producing method thereof | |
KR101931350B1 (en) | Feed composition for freshwater eels | |
KR102005795B1 (en) | Method for producng functional tea using Cudrania tricuspidata | |
KR20090061114A (en) | Health functional chrysanthemun vinegar ane process for preparation thereof | |
CN105886324B (en) | A kind of Selenium-enriched fermentation method of indole-3-carbinol and indole -3-acetonitrile in raising fruit vinegar | |
KR101760052B1 (en) | Preparing Method of Sorghum Extract having High Antioxidant Activity and the Sorghum Extract having High Antioxidant Activity thereby | |
KR102624448B1 (en) | Method for producing functional fermented ginseng seed extract using grain mushroom mycelium seed culture | |
KR102422395B1 (en) | Manufacturing Method of Steamed Bread using Brown Rice | |
KR102444816B1 (en) | Preparing method of the functional rice paste using mulberry leaves, mulberry and glutinous rice | |
KR102190772B1 (en) | Method for producing soybean paste and soy sauce adding Rhus verniciflua fermented extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GRNT | Written decision to grant |